Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growthJyoti Patel(University of Maryland, Baltimore), Vincent C.O. Njar(University of Maryland, Baltimore)British Journal of CancerMarch 27, 200710.1038/sj.bjc.6603705Cited by 40SaveCiteExport RISWatch citationsRelated PapersSimultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines|Oncotarget|2014|25Targeted Degradation of Androgen Receptor by VNPP433-3β in Castration-Resistant Prostate Cancer Cells Implicates Interaction with E3 Ligase MDM2 Resulting in Ubiquitin-Proteasomal Degradation|Cancers|2023|17Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models|Cells|2022|15Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model|Bioorganic Chemistry|2023|11